Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
Following the results of a recent study which showed that Eli Lilly’s sepsis drug, Xigris, provided no better results in reducing mortality than that of a placebo, the pharmaceutical company announced it will pull the product from the market worldwide. Both The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have [...]
According to a study published on October 25 in The British Medical Journal, newer-generation birth control pills, specifically those containing the progestogen hormones drospirenone, desogestrel or gestodene, double the risk for venous thromboembolism (VTE), compared to older-generation contraceptives containing the progestogen hormone, levonorgestrel. Best-selling brands and generics like Yaz and Ocella are examples of the [...]
The U.S. Food and Drug Administration has released an updated safety communication regarding drospirenone-containing birth control pills, following its review of the results from an agency-funded study. According to the FDA, Bayer Pharmaceutical’s widely-used birth control pills, Yaz and Yasmin, are 75 percent more likely to cause blood clots in women than older-generation pills. The [...]
